Dianthus Therapeutics | 4:持股变动声明-高管 CARR EDWARD
Dianthus Therapeutics | 4:持股变动声明-高管 Veness Adam M
Dianthus Therapeutics | 4:持股变动声明-高管 Randhawa Simrat
Dianthus Therapeutics | 4:持股变动声明-高管 Savitz Ryan
Dianthus Therapeutics | 4:持股变动声明-高管 Garcia Marino
Dianthus Therapeutics | 4:持股变动声明-董事 Violin Jonathan
Dianthus Therapeutics | 4:持股变动声明-董事 Soteropoulos Paula
Dianthus Therapeutics | 4:持股变动声明-董事 MOULDER LEON O JR
Dianthus Therapeutics | 4:持股变动声明-董事 McGeorge Anne
Dianthus Therapeutics | 4:持股变动声明-董事 Lawton Alison Frances
Dianthus Therapeutics | 4:持股变动声明-董事 Fairmount Funds Management LLC
Dianthus Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Fairmount Funds Management LLC(9.99%),Fairmount Healthcare Fund II LP(9.99%)等
Dianthus Therapeutics | 4:持股变动声明-董事 Fairmount Funds Management LLC
Dianthus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Andrew J. Schwab(5.7%),Kush Parmar(5.7%)等
Dianthus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Third Rock Ventures IV, L.P.(0%),Third Rock Ventures GP IV, L.P.(0%)等
Dianthus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Citadel Advisors LLC(0.0%),Citadel Advisors Holdings LP(0.0%)等
Dianthus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-GV 2016, L.P.(1.4%),GV 2016 GP, L.P.(1.4%)等
Dianthus Therapeutics | SC 13G:超过5%持股股东披露文件-BCLS Fund III Investments, LP(9.99%)
Dianthus Therapeutics | SC 13G:超过5%持股股东披露文件-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%)等
Dianthus Therapeutics | SC 13D:超过5%持股股东披露文件-Avidity Partners Management LP(9.9%),Avidity Partners Management (GP) LLC(9.9%)等
暂无数据